52W Range | $1.71-$5 |
Shares Short | 589 |
Revenue (12 Mos) | $393.9M |
Revenue Growth (YoY) | 478.6% |
Gross Profit (12 Mos) | $232.5M |
Diluted EPS | $0 |
CEO | Mr. Robert Wessman |
Address | 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 999 |